FeetMe, Idinvest healthcare portfolio company, announces the closing of a seed round
FeetMe, a medical device company that produces smart and connected insoles for improved running, walking and gait analysis, today announced it has raised € 1.95 million in seed funding. The investment round was led by Kurma Diagnostics, with additional investment from the new Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV (a current shareholder of FeetMe). The innovative technology from FeetMe allows gait and posture analysis in real-time and real-life conditions. The technology combines pressure sensors, motion sensors and learning algorithms to analyse patients' functional capacity, as well as empower rehabilitation among sufferers of gait disorders.